Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A (PLEO-CMT-FU)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03023540 |
|
Recruitment Status :
Active, not recruiting
First Posted : January 18, 2017
Last Update Posted : February 20, 2024
|
Sponsor:
Pharnext S.C.A.
Collaborators:
Synteract HCR (Syneos Health)
Premier Research Group plc
Greenphire
Theradis
Amarex
Eurofins Optimed
Information provided by (Responsible Party):
Pharnext S.C.A.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | December 31, 2024 |
| Estimated Study Completion Date : | December 31, 2024 |